Management of HCC
References (181)
- et al.
Primary liver cancer: worldwide incidence and trends
Gastroenterology
(2004) - et al.
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients
Gastroenterology
(1997) - et al.
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease
Gastroenterology
(2009) - et al.
Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
Hepatology
(2003) - et al.
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus
Hepatology
(2002) - et al.
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
Gastroenterology
(2004) - et al.
Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism
Am J Hum Genet
(2011) - et al.
Principles of cancer screening: lessons from history and study design issues
Semin Oncol
(2010) Serological surveillance for hepatocellular carcinoma: time to quit
J Hepatol
(2010)- et al.
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial
J Hepatol
(2005)
Desgamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients
Hepatology
(2003)
Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma
Gastroenterology
(2003)
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma
Gastroenterology
(2009)
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance
Gastroenterology
(2004)
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival
J Hepatol
(2010)
The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma
J Hepatol
(2009)
Changing international trends in mortality rates for liver, biliary and pancreatic tumours
J Hepatol
(2002)
Prospective validation of the Barcelona Clinic Liver Cancer staging system
J Hepatol
(2006)
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver
J Hepatol
(2001)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
Lancet
(2002)
Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan
Hepatology
(2000)
Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation
Gastroenterology
(2004)
A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma
Gastroenterology
(2005)
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
Hepatology
(2002)
Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey
Surgery
(2008)
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
J Hepatol
(2003)
A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma
Gastroenterology
(2009)
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies
J Hepatol
(2006)
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma
Gastroenterology
(2008)
Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma
Hum Pathol
(2008)
Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma
HPB (Oxford)
(2010)
Gene-expression signature of vascular invasion in hepatocellular carcinoma
J Hepatol
(2011)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Int J Cancer
(2010)
Natural history of hepatitis-related hepatocellular carcinoma
World J Gastroenterol
(2008)
Natural history and prognostic factors for chronic hepatitis type B
Gut
(1991)
Hepatitis B e antigen and the risk of hepatocellular carcinoma
N Engl J Med
(2002)
Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
J Clin Oncol
(2010)
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China
Cancer Epidemiol Biomarkers Prev
(1994)
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death
Gut
(2000)
Management of hepatocellular carcinoma: an update
Hepatology
(2011)
Alcoholic liver disease
Hepatology
(2010)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults
N Engl J Med
(2003)
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
Science
(2007)
Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis
Aliment Pharmacol Ther
(2009)
Computed tomography-an increasing source of radiation exposure
N Engl J Med
(2007)
Correlation between clinical indication for treatment and liver histology in HBeAg-negative chronic hepatitis B: a novel role of alpha-fetoprotein
Liver Int
(2010)
Alpha-fetoprotein-producing clear cell carcinoma of the extrahepatic bile ducts
J Clin Gastroenterol
(2006)
Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases
J Surg Oncol
(2010)
Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity
Cancer
(1999)
Randomized controlled trial of screening for hepatocellular carcinoma
J Cancer Res Clin Oncol
(2004)
Cited by (0)
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier Ireland Ltd. All rights reserved.